Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04565249
What this trial is testing

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Who this might be right for
Acute Respiratory Distress SyndromeSARS-CoV-2
Pliant Therapeutics, Inc. 6
Post-approval studies (Phase 4)Ended earlyNCT04335786
What this trial is testing

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Who this might be right for
Acute Respiratory Distress SyndromeSARS-CoV-2COVID+2 more
Radboud University Medical Center 23
Testing effectiveness (Phase 2)Study completedNCT04686773
What this trial is testing

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

Who this might be right for
COVID-19
R-Pharm 100
Large-scale testing (Phase 3)UnknownNCT04528888
What this trial is testing

Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection

Who this might be right for
Covid19SARS-CoV InfectionPneumonia, Viral+1 more
Massimo Girardis 210
Large-scale testing (Phase 3)Study completedNCT04402970
What this trial is testing

Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)

Who this might be right for
SARS-CoV 2ARDS
University of Missouri-Columbia 30
Not applicableStudy completedNCT04723446
What this trial is testing

Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva

Who this might be right for
Covid19Coronavirus
Queen Mary University of London 54
Large-scale testing (Phase 3)Ended earlyNCT05531149
What this trial is testing

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Who this might be right for
Respiratory InfectionPneumoniaCommunity-acquired Pneumonia+5 more
Biotest 107
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Not applicableStudy completedNCT04681001
What this trial is testing

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Who this might be right for
Respiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) Pneumonia+2 more
Marinomed Biotech AG 300
Testing effectiveness (Phase 2)Ended earlyNCT04365101
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Who this might be right for
CoronavirusCoronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2+17 more
Celularity Incorporated 7
Early research (Phase 1)Study completedNCT04519437
What this trial is testing

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 974
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Large-scale testing (Phase 3)Study completedNCT05543616
What this trial is testing

Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

Who this might be right for
SARS-CoV-2 VirusSevere Acute Respiratory Syndrome Coronavirus 2COVID-19
BioNTech SE 4,338
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512
Not applicableStudy completedNCT04516928
What this trial is testing

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel

Who this might be right for
SARS-CoV InfectionCovid19
Direction Centrale du Service de Santé des Armées 392
Large-scale testing (Phase 3)Study completedNCT04501978
What this trial is testing

ACTIV-3: Therapeutics for Inpatients With COVID-19

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 2,753
Testing effectiveness (Phase 2)Ended earlyNCT04511650
What this trial is testing

Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019

Who this might be right for
COVID-19Acute Respiratory Distress Syndrome (ARDS)
EyePoint Pharmaceuticals, Inc. 31
Not applicableStudy completedNCT04367740
What this trial is testing

ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19

Who this might be right for
Asymptomatic ConditionInfection ViralCoronavirus Infections+5 more
University of North Carolina, Chapel Hill 6,313
Testing effectiveness (Phase 2)Ended earlyNCT04342897
What this trial is testing

LY3127804 in Participants With COVID-19

Who this might be right for
COVID-19Pneumonia
Eli Lilly and Company 95
Next Page